The Safety, Clinical, and Neurophysiological Effects of Intranasal Ketamine in Patients Who Do Not Respond to Electroconvulsive Therapy: Protocol for a Pilot, Open-Label Clinical Trial

Yuliya Knyahnytska   ^{1 *} , MD, PhD ;   Reza Zomorrodi   ^{1 *} , PhD ;   Tyler Kaster   ^{1 *} , MD ;   Daphne Voineskos   ^{1 *} , MD, PhD ;   Alisson Trevizol   ^{1 *} , MD ;   Daniel Blumberger   ^{1 *} , MD, MSc

¹ Centre for Addiction and Mental Health, Toronto, ON, Canada

*all authors contributed equally